Platelet‐rich plasma in the treatment of alopecia areata after <scp>COVID</scp>‐19 vaccination
Hsiang‐Chiun Teng, Hsin‐Hsu Chen
Abstract
Key Clinical Message: Alopecia areata may develop in patients after COVID-19 vaccination. Platelet-rich plasma (PRP) has an outstanding anti-inflammatory effect and could be an alternative treatment for alopecia patients who are refractory or intolerant to corticosteroids. Abstract: A 34-year-old female with no systemic illness presented with non-scarring hair loss after the second COVID-19 vaccination shot 4 weeks ago. The hair loss worsened and progressed to severe alopecia areata. We started double-spin PRP therapy. Her hair recovered completely after six courses of PRP treatment.
Topics & Concepts
MedicineAlopecia areataCoronavirus disease 2019 (COVID-19)VaccinationPlatelet-rich plasma2019-20 coronavirus outbreakPlateletSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyDermatologyVirologyInternal medicineOutbreakDiseaseInfectious disease (medical specialty)Hair Growth and DisordersDermatologic Treatments and ResearchFacial Rejuvenation and Surgery Techniques